# FDA Inspection 904185 - Amgen, Inc. - November 14, 2014

Source: https://www.keypedia.com/records/fda_inspections/amgen-inc/8561707e-e590-4a97-8b84-2e6c4e647336
Source feed: FDA_Inspections

> FDA Inspection 904185 for Amgen, Inc. on November 14, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 904185
- Company Name: Amgen, Inc.
- Inspection Date: 2014-11-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1278976 - 2025-08-07](https://www.keypedia.com/records/fda_inspections/amgen-inc/d97d8a62-a229-4000-9007-f563754eede5)
- [FDA Inspection 1278976 - 2025-08-07](https://www.keypedia.com/records/fda_inspections/amgen-inc/41a4234d-3f2f-4bab-ab8b-9a1e17008055)
- [FDA Inspection 1256132 - 2025-03-13](https://www.keypedia.com/records/fda_inspections/amgen-inc/8601b5a4-a27d-4f90-9399-1e0398db8be7)
- [FDA Inspection 1220409 - 2023-09-14](https://www.keypedia.com/records/fda_inspections/amgen-inc/78815a66-7fde-4e3c-b744-48f87db72016)
- [FDA Inspection 1112791 - 2019-12-13](https://www.keypedia.com/records/fda_inspections/amgen-inc/f7c02d35-9f41-4022-9b49-996bf75204ed)

Company: https://www.keypedia.com/companies/amgen-inc/85ec512e-6991-42ee-9cd5-148cfe0ed3e8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c